Teva

The Statista dossier
  • Detailed references
  • Editorially prepared
  • Download as PDF / PPT

Statista dossier about the pharmaceutical company Teva Pharmaceutical Industries

Table of contents

  • 1. Market overview
    • Total worldwide prescription drug revenue - projection 2016-2026

    • Worldwide generic prescription drug revenue 2012-2026

    • Top 50 pharmaceutical companies - Rx sales and R&D spending 2019

    • Revenues of leading global generics manufacturers 2019

    • Biosimilars in development and approved by FDA 2019, by manufacturer

  • 2. Key numbers
    • Teva Pharmaceutical Industries' revenue 2006-2020

    • Teva Pharmaceutical Industries' net income 2006-2020

    • Teva Pharmaceutical Industries' total assets 2011-2020

    • Teva Pharmaceutical Industries: earnings per share 2006-2020

    • Teva Pharmaceutical's number of employees 2018-2020 by region

  • 3. Regions and segments
    • Teva Pharmaceutical Industries's revenue 2018-2020 by region

    • Teva Pharmaceutical Industries' generic revenues by region 2016-2020

    • Teva Pharmaceutical Industries' specialty medicines revenues breakdown 2018-2020

  • 4. Costs and expenses
    • Teva: expenditure on research and development 2006-2020

    • Teva Pharmaceutical Industries' selling and marketing expenses 2011-2020

    • Teva Pharmaceutical Industries' legal settlements 2014-2020

More than 7,500
companies
trust
Statista

Recommended studies and dossiers

Recent studies and dossiers

You may also be interested in...

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!